press_release

MHRA Suspends Licences for Medicine Manufacturers and Wholesalers in GB

United Kingdom·Briefly Analysis⏱️ 2 min read

Summary

  • The MHRA has suspended or revoked licences for several manufacturers and wholesalers of medicines and ingredients in the UK.
  • Companies that have had their licences suspended or revoked are no longer authorized to manufacture or wholesale medicines and ingredients.
  • The list of suspensions and revocations is updated regularly on the GOV.UK website.
  • Companies operating in the pharmaceutical supply chain must ensure they are dealing with valid licence holders to avoid regulatory risks.

What Happened

Companies that have had their licences suspended or revoked are no longer authorized to manufacture or wholesale medicines and ingredients.

The Medicines and Healthcare products Regulatory Agency (MHRA) has taken action against several manufacturers and wholesalers of medicines and ingredients in the UK. The agency has suspended or revoked licences for these companies, which are listed on a public document available on the GOV.UK website. This list is updated regularly to reflect any changes to licence status. Companies that have had their licences suspended or revoked are no longer authorized to manufacture or wholesale medicines and ingredients.

Legal Context

The MHRA has the authority to suspend or revoke licences for manufacturers and wholesalers of medicines and ingredients if certain conditions are met. These conditions include failure to comply with regulatory requirements, inadequate quality control measures, or other serious breaches of licence terms. The agency may also permanently revoke a licence in extreme circumstances. Companies that operate in the pharmaceutical supply chain must ensure they are dealing with valid licence holders to avoid regulatory risks.

Why It Matters

The suspension or revocation of licences for manufacturers and wholesalers has significant implications for the pharmaceutical supply chain. Companies that rely on these suppliers may face disruptions in their operations, and could be exposed to regulatory risks if they continue to deal with non-compliant licence holders. Lawyers and compliance officers should review the updated list of suspended licences to ensure they are dealing with valid licence holders.

Practical Implications

Lawyers and compliance officers should review the updated list of suspended licences to ensure they are dealing with valid licence holders, as non-compliance may expose them to regulatory risks.

Source

Source: Original reporting via GOV.UK

Get Deeper AI analysis

How does this affect you?

Get an AI analysis of this article grounded in your jurisdictions, practice areas, and any policy documents you've uploaded to Wansom.

Wansom is AI and can make mistakes.